Protagonist Therapeutics (PTGX) Stock
Protagonist Therapeutics (PTGX) closed at $124.67 on Nov 17, 2026; its Tenet Score is 65 of 100 against 340 Healthcare peers.
9 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $124.67
- Nov 17, 2026
- Market cap
- $8.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 26.2×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 77.00 – 160.81
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 65/100
- Solid · 340 Healthcare peers
Industry: Drugs
Protagonist Therapeutics Inc scores 65/100. Solid. Strongest on financial health and quality, value is the soft spot, trading at 26× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✕ Piotroski F-Score
- ✓ Munger Compounders
- ~ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectab…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Krystal Biotech IncKRYS | 66 | $8.8B |
| Praxis Precision Medicines IncPRAX | 46 | $8.7B |
| Alkermes plcALKS | 37 | $7.8B |
| Corcept Therapeutics IncCORT | 54 | $7.6B |
| Rhythm Pharmaceuticals Inc.RYTM | 36 | $7.5B |
| Cytokinetics IncCYTK | 34 | $7.4B |
| Kiniksa Pharmaceuticals International Plc.KNSA | 55 | $7.4B |
| Amneal Pharmaceuticals IncAMRX | 39 | $7.4B |
| Axsome Therapeutics IncAXSM | 31 | $7.2B |
| Twist Bioscience CorpTWST | 48 | $7.2B |
Common questions
What sector and industry is Protagonist Therapeutics in?
Protagonist Therapeutics is in the Healthcare sector and the Drugs industry.
What is Protagonist Therapeutics' Tenet Score?
Protagonist Therapeutics' Tenet Score is 65 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




